← Open Payments lookup

DEBORAH MEWBOURNE: Open Payments

NPI 1538397633 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,733 in 73 payments from 18 companies in 2025. Trend: 2023 $1,780 · 2024 $1,765 · 2025 $1,733

Food & beverage: $1,733
CompanyPaymentsAmount
Janssen Biotech, Inc.7$355
Novartis Pharmaceuticals Corporation16$276
ABBVIE INC.10$205
AstraZeneca Pharmaceuticals LP5$191
Bayer Healthcare Pharmaceuticals Inc.6$156
Lilly USA, LLC5$80
Genmab U.S., Inc.3$68
Daiichi Sankyo Inc.4$64
PFIZER INC.3$61
Aveo Pharmaceuticals, Inc.3$60

Products named: RYBREVANT, EPKINLY, Nubeqa, CALQUENCE, SCEMBLIX, VERZENIO, VENCLEXTA, KISQALI.

Industry payments across OK — which companies pay providers there.